The World Anti-Doping Agency may consider imposing longer bans on athletes using banned substances if research on steroid longevity proves valid.
Research conducted on mice in Oslo, Norway, suggests some drugs could benefit athletes after their bans expire.
WADA, according to a BBC report, has welcomed the findings of University of Oslo Physiology Professor Kristian Gundersen.
Gundersen's research suggests muscles can retain the advantages given by anabolic steroids decades after the point at which they were taken.
Thsi finding could also have major implications for the existing anti-doping system, where a first-time offender is unlikely to be suspended for more than two years and may well serve less than half that.
WADA's Dr. Rabin said that if these results do demonstrate there is an issue beyond two or four years, WADA committees would examine the possibility of revising the existing code and consider a change of rules, if required.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
